scholarly article | Q13442814 |
P50 | author | Louanne Hudgins | Q92012453 |
P2093 | author name string | Kelly Ormond | |
Leah Slattery | |||
Gregory Kellogg | |||
P2860 | cites work | Practice Guidelines for Communicating a Prenatal or Postnatal Diagnosis of Down Syndrome: Recommendations of the National Society of Genetic Counselors | Q22252626 |
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
Which neurodevelopmental disorders get researched and why? | Q28744534 | ||
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study | Q30414408 | ||
Characteristics of women who refuse an offer of prenatal diagnosis: data from the California maternal serum alpha fetoprotein blood test experience | Q32035411 | ||
DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. | Q34249522 | ||
Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
Non-invasive prenatal testing: ethical issues explored | Q34328617 | ||
"Testing times, challenging choices": an Australian study of prenatal genetic counseling | Q35006143 | ||
Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake | Q35577099 | ||
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
ACMG statement on noninvasive prenatal screening for fetal aneuploidy. | Q38096182 | ||
With new prenatal testing, will babies with Down syndrome slowly disappear? | Q39970536 | ||
The role of genetic counseling in the elective termination of pregnancies involving fetuses with disabilities | Q40237764 | ||
Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors | Q44274066 | ||
Get ready for the flood of fetal gene screening | Q46556601 | ||
The decision to continue a pregnancy affected by Down syndrome: timing of decision and satisfaction with receiving a prenatal diagnosis | Q46941417 | ||
Genetic counseling for prenatal testing: where is the discussion about disability? | Q47254779 | ||
Commentary: how individual and profession-level factors influence discussion of disability in prenatal genetic counseling | Q48558693 | ||
Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly. | Q51821173 | ||
The relationship between the genetic counseling profession and the disability community: a commentary. | Q53084215 | ||
Attitudes towards prenatal diagnosis and termination in women who have a sibling with Down's syndrome | Q54888404 | ||
Prenatal testing for Down syndrome: the perspectives of parents of individuals with Down syndrome. | Q55691711 | ||
Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age | Q82457925 | ||
Attitudes toward non-invasive prenatal diagnosis among pregnant women and health professionals in Japan | Q84061718 | ||
National profile of children with Down syndrome: disease burden, access to care, and family impact | Q84319117 | ||
Embracing the unique role of genetic counselors: response to the commentary by Madeo et al | Q84523927 | ||
Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy | Q85495453 | ||
P433 | issue | 5 | |
P921 | main subject | Down syndrome | Q47715 |
P304 | page(s) | 805-813 | |
P577 | publication date | 2014-02-01 | |
P1433 | published in | Journal of Genetic Counseling | Q6295247 |
P1476 | title | Attitudes of mothers of children with down syndrome towards noninvasive prenatal testing | |
P478 | volume | 23 |
Q55173016 | "This lifetime commitment": Public conceptions of disability and noninvasive prenatal genetic screening. |
Q38780309 | A Framework for Unrestricted Prenatal Whole-Genome Sequencing: Respecting and Enhancing the Autonomy of Prospective Parents |
Q47586884 | Attitudes towards non-invasive prenatal diagnosis among obstetricians in Pakistan, a developing, Islamic country |
Q39387768 | Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy |
Q61448634 | Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences |
Q48352229 | Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome? |
Q91779483 | Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory |
Q41253896 | Informed decision-making about prenatal cfDNA screening: An assessment of written materials. |
Q89961817 | Is preparation a good reason for prenatal genetic testing? Ethical and critical questions |
Q59209275 | Non-invasive prenatal screening for trisomy 21: Consumers' perspectives |
Q98222200 | Non-invasive prenatal testing (NIPT): societal pressure or freedom of choice? A vignette study of Dutch citizens' attitudes |
Q39113200 | Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives |
Q26999426 | Non-invasive prenatal testing: a review of international implementation and challenges |
Q64232954 | Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment |
Q35845489 | Old Questions, New Paradigms: Ethical, Legal, and Social Complications of Noninvasive Prenatal Testing |
Q40188449 | Patient preferences for prenatal testing of microdeletion and microduplication syndromes |
Q64236032 | Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis |
Q93265239 | Physicians' perception toward non-invasive prenatal testing through the eye of the Rogers' diffusion of innovation theory in China |
Q52855653 | Population screening for spinal muscular atrophy: A mixed methods study of the views of affected families. |
Q36022080 | Positive Attitudes towards Non-Invasive Prenatal Testing (NIPT) in a Swedish Cohort of 1,003 Pregnant Women |
Q39487915 | Survey of attitudes of Chinese perinatologists and obstetricians toward non-invasive prenatal genetic testing |
Q26998800 | Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond |
Q33634130 | What Do Parents of Children with Down Syndrome Think about Non-Invasive Prenatal Testing (NIPT)? |
Q47640924 | Women's Understanding and Attitudes towards Down Syndrome and Other Genetic Conditions in the Context of Prenatal Screening |
Q39177461 | Women's choices for invasive or non-invasive testing: influence of gestational age and service delivery |
Search more.